The Tiotropium Safety and Performance in Respimat® (TIOSPIR®) Trial: Spirometry Outcomes

[1]  G. Pledger,et al.  Tiotropium Respimat inhaler and the risk of death in COPD. , 2013, The New England journal of medicine.

[2]  G. Pledger,et al.  The Tiotropium Safety and Performance in Respimat (TIOSPIR) trial: Bronchodilator efficacy in a spirometry substudy , 2013 .

[3]  G. Pledger,et al.  The Tiotropium Safety and Performance in Respimat® Trial (TIOSPIR®), a large scale, randomized, controlled, parallel-group trial-design and rationale , 2013, Respiratory Research.

[4]  C. Tantucci,et al.  Lung function decline in COPD , 2012, International journal of chronic obstructive pulmonary disease.

[5]  L. Edwards,et al.  Changes in forced expiratory volume in 1 second over time in COPD. , 2011, The New England journal of medicine.

[6]  E. Bateman,et al.  A one-year trial of tiotropium Respimat plus usual therapy in COPD patients. , 2010, Respiratory medicine.

[7]  M. Decramer,et al.  Treatment of COPD: the sooner the better? , 2010, Thorax.

[8]  E. Bateman,et al.  International Journal of Copd Dovepress Dovepress Efficacy and Safety of Tiotropium Respimat ® Smi in Copd in Two 1-year Randomized Studies , 2022 .

[9]  M. Decramer,et al.  Cardiovascular safety of tiotropium in patients with COPD. , 2010, Chest.

[10]  M. Decramer,et al.  Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease. , 2009, American journal of respiratory and critical care medicine.

[11]  M. Decramer,et al.  A 4-year trial of tiotropium in chronic obstructive pulmonary disease. , 2008, The New England journal of medicine.

[12]  P. Calverley,et al.  Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. , 2008, American journal of respiratory and critical care medicine.

[13]  Yahong Peng,et al.  Recommendations for the Primary Analysis of Continuous Endpoints in Longitudinal Clinical Trials , 2008 .

[14]  A. Anzueto,et al.  One-year analysis of longitudinal changes in spirometry in patients with COPD receiving tiotropium. , 2005, Pulmonary pharmacology & therapeutics.

[15]  Nicholas J Gross,et al.  Tiotropium Bromide , 2012 .

[16]  R. Zuwallack,et al.  A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease , 2002, European Respiratory Journal.

[17]  R. Casaburi,et al.  Tiotropium bromide. Commentaries , 2002 .

[18]  J E Cotes,et al.  Lung volumes and forced ventilatory flows , 1993, European Respiratory Journal.

[19]  J E Cotes,et al.  Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. , 1993, The European respiratory journal. Supplement.

[20]  R. Peto,et al.  The natural history of chronic airflow obstruction. , 1977, British medical journal.